M. Berk and A. Nierenberg, Three Paths to Drug Discovery in Psychiatry, American Journal of Psychiatry, vol.172, issue.5, pp.412-416, 2015.
DOI : 10.1176/appi.ajp.2014.14070858

M. Berk, L. Williams, F. Jacka, O. Neil, A. Pasco et al., So depression is an inflammatory disease, but where does the inflammation come from?, BMC Medicine, vol.79, issue.1, 0200.
DOI : 10.1186/1741-7015-11-200

G. Khandaker, L. Cousins, J. Deakin, B. Lennox, R. Yolken et al., Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment, The Lancet Psychiatry, vol.2, issue.3, pp.258-70, 2015.
DOI : 10.1016/S2215-0366(14)00122-9

A. Modabbernia, S. Taslimi, E. Brietzke, and M. Ashrafi, Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies, Biological Psychiatry, vol.74, issue.1, pp.15-25, 2013.
DOI : 10.1016/j.biopsych.2013.01.007

B. Miller, P. Buckley, W. Seabolt, A. Mellor, and B. Kirkpatrick, Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects, Biological Psychiatry, vol.70, issue.7, pp.663-71, 2011.
DOI : 10.1016/j.biopsych.2011.04.013

A. Brown, The Kraepelinian Dichotomy From the Perspective of Prenatal Infectious and Immunologic Insults: Table 1., Schizophrenia Bulletin, vol.41, issue.4, pp.786-91, 2015.
DOI : 10.1093/schbul/sbv063

A. Danese, C. Pariante, A. Caspi, A. Taylor, and R. Poulton, Childhood maltreatment predicts adult inflammation in a life-course study, Proceedings of the National Academy of Sciences, vol.104, issue.4, pp.1319-1343, 2007.
DOI : 10.1073/pnas.0610362104

W. Copeland, D. Wolke, S. Lereya, L. Shanahan, C. Worthman et al., Childhood bullying involvement predicts low-grade systemic inflammation into adulthood, Proceedings of the National Academy of Sciences, vol.111, issue.21, pp.7570-7575, 2014.
DOI : 10.1073/pnas.1323641111

J. Rosenblat and R. Mcintyre, Are medical comorbid conditions of bipolar disorder due to immune dysfunction?, Acta Psychiatrica Scandinavica, vol.70, issue.3, pp.180-91, 2015.
DOI : 10.1111/acps.12414

A. Niculescu, D. Levey, H. Le-niculescu, E. Niculescu, S. Kurian et al., Psychiatric blood biomarkers: avoiding jumping to premature negative or positive conclusions, Molecular Psychiatry, vol.20, issue.3, pp.286-294, 2015.
DOI : 10.1016/j.biopsych.2014.01.022

P. Mcgorry, M. Keshavan, S. Goldstone, P. Amminger, K. Allott et al., Biomarkers and clinical staging in psychiatry, World Psychiatry, vol.167, issue.43, pp.211-234, 2014.
DOI : 10.1002/wps.20144

R. Dantzer, O. Connor, J. Freund, G. Johnson, R. Kelley et al., From inflammation to sickness and depression: when the immune system subjugates the brain, Nature Reviews Neuroscience, vol.17, issue.1, pp.46-56, 2008.
DOI : 10.1038/nrn2297

E. Hsiao, Immune Dysregulation in Autism Spectrum Disorder, Int Rev Neurobiol, vol.113, pp.269-302, 2013.
DOI : 10.1016/B978-0-12-418700-9.00009-5

M. Benros, B. Waltoft, M. Nordentoft, S. Ostergaard, W. Eaton et al., Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders, JAMA Psychiatry, vol.70, issue.8, pp.812-832, 2013.
DOI : 10.1001/jamapsychiatry.2013.1111

S. Chen, X. Zhong, L. Jiang, X. Zheng, Y. Xiong et al., Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: A systematic review and meta-analysis, Behavioural Brain Research, vol.296, pp.61-70, 2016.
DOI : 10.1016/j.bbr.2015.08.035

H. Atladottir, P. Thorsen, L. Ostergaard, D. Schendel, S. Lemcke et al., Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders, Journal of Autism and Developmental Disorders, vol.33, issue.3, pp.1423-1453, 2010.
DOI : 10.1007/s10803-010-1006-y

V. Bergink, S. Gibney, and H. Drexhage, Autoimmunity, Inflammation, and Psychosis: A Search for Peripheral Markers, Biological Psychiatry, vol.75, issue.4, pp.324-355, 2014.
DOI : 10.1016/j.biopsych.2013.09.037

A. Brown, A. Sourander, S. Hinkka-yli-salomaki, I. Mckeague, J. Sundvall et al., Elevated maternal C-reactive protein and autism in a national birth cohort, Molecular Psychiatry, vol.29, issue.2, pp.259-64, 2014.
DOI : 10.1016/j.bbi.2010.09.013

S. Vuillermot, E. Joodmardi, T. Perlmann, S. Ogren, J. Feldon et al., Prenatal Immune Activation Interacts with Genetic Nurr1 Deficiency in the Development of Attentional Impairments, Journal of Neuroscience, vol.32, issue.2, pp.436-51, 2012.
DOI : 10.1523/JNEUROSCI.4831-11.2012

S. Ripke, O. Dushlaine, C. Chambert, K. Moran, J. Kahler et al., Genome-wide association analysis identifies 13 new risk loci for schizophrenia, Nature Genetics, vol.72, issue.10, pp.1150-1159, 2013.
DOI : 10.1176/appi.ajp.2012.11091423

J. Oliveira, M. Busson, B. Etain, S. Jamain, N. Hamdani et al., Polymorphism of Toll-like receptor 4 gene in bipolar disorder, Journal of Affective Disorders, vol.152, issue.154, pp.152-154395, 2014.
DOI : 10.1016/j.jad.2013.09.043

R. Kazma, J. Mefford, I. Cheng, S. Plummer, A. Levin et al., Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk, PLoS ONE, vol.106, issue.12, p.51680, 2012.
DOI : 10.1371/journal.pone.0051680.s002

I. Voineagu and V. Eapen, Converging Pathways in Autism Spectrum Disorders: Interplay between Synaptic Dysfunction and Immune Responses, Frontiers in Human Neuroscience, vol.7, p.738, 2013.
DOI : 10.3389/fnhum.2013.00738

A. Pocklington, E. Rees, J. Walters, J. Han, D. Kavanagh et al., Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia, Neuron, vol.86, issue.5, pp.1203-1217, 2015.
DOI : 10.1016/j.neuron.2015.04.022

O. Mahony, S. Marchesi, J. Scully, P. Codling, C. Ceolho et al., Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses, Biological Psychiatry, vol.65, issue.3, pp.263-270, 2009.
DOI : 10.1016/j.biopsych.2008.06.026

R. Coelho, T. Viola, C. Walss-bass, E. Brietzke, and R. Grassi-oliveira, Childhood maltreatment and inflammatory markers: a systematic review, Acta Psychiatrica Scandinavica, vol.71, issue.3, pp.180-92, 2014.
DOI : 10.1111/acps.12217

B. Etain, M. Aas, O. Andreassen, S. Lorentzen, I. Dieset et al., Childhood Trauma Is Associated With Severe Clinical Characteristics of Bipolar Disorders, The Journal of Clinical Psychiatry, vol.74, issue.10, pp.991-999, 2013.
DOI : 10.4088/JCP.13m08353

H. Sun, D. Damez-werno, K. Scobie, N. Shao, C. Dias et al., ACF chromatin-remodeling complex mediates stress-induced depressive-like behavior, Nature Medicine, vol.21, issue.10, pp.1146-53, 2015.
DOI : 10.1101/gr.142067.112

J. Davis, S. Moylan, B. Harvey, M. Maes, and M. Berk, Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries, Australian & New Zealand Journal of Psychiatry, vol.39, issue.3, pp.512-541, 2014.
DOI : 10.1177/0004867414533012

H. Krugers, C. Hoogenraad, and L. Groc, Stress hormones and AMPA receptor trafficking in synaptic plasticity and memory, Nature Reviews Neuroscience, vol.21, issue.10, pp.675-81, 2010.
DOI : 10.1038/nrn2913

H. Krugers and M. Joels, Long-lasting Consequences of Early Life Stress on Brain Structure, Emotion and Cognition, Curr Top Behav Neurosci, vol.18, pp.81-92, 2014.
DOI : 10.1007/7854_2014_289

J. Felger, E. Haroon, and A. Miller, Risk and Resilience: Animal Models Shed Light on the Pivotal Role of Inflammation in Individual Differences in Stress-Induced Depression, Biological Psychiatry, vol.78, issue.1, pp.7-9, 2015.
DOI : 10.1016/j.biopsych.2015.04.017

J. Jerrell, R. Mcintyre, and A. Tripathi, A Cohort Study of the Prevalence and Impact of Comorbid Medical Conditions in Pediatric Bipolar Disorder, The Journal of Clinical Psychiatry, vol.71, issue.11, pp.1518-1543, 2010.
DOI : 10.4088/JCP.09m05585ora

O. Godin, B. Etain, C. Henry, T. Bougerol, P. Courtet et al., Metabolic Syndrome in a French Cohort of Patients With Bipolar Disorder, The Journal of Clinical Psychiatry, vol.75, issue.10, pp.1078-85, 2014.
DOI : 10.4088/JCP.14m09038

G. Khandaker, R. Pearson, S. Zammit, G. Lewis, and P. Jones, Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life, JAMA Psychiatry, vol.71, issue.10, pp.1121-1129, 2014.
DOI : 10.1001/jamapsychiatry.2014.1332

M. Ellenbogen, J. Santo, A. Linnen, C. Walker, and S. Hodgins, High cortisol levels in the offspring of parents with bipolar disorder during two weeks of daily sampling, Bipolar Disorders, vol.114, issue.1, pp.77-86, 2010.
DOI : 10.1111/j.1399-5618.2009.00770.x

J. Pasco, F. Jacka, L. Williams, M. Henry, G. Nicholson et al., Leptin in depressed women: Cross-sectional and longitudinal data from an epidemiologic study, Journal of Affective Disorders, vol.107, issue.1-3, pp.1-3221, 2008.
DOI : 10.1016/j.jad.2007.07.024

D. Coury, P. Ashwood, A. Fasano, G. Fuchs, M. Geraghty et al., Gastrointestinal Conditions in Children With Autism Spectrum Disorder: Developing a Research Agenda, PEDIATRICS, vol.130, issue.Supplement, pp.160-168, 2012.
DOI : 10.1542/peds.2012-0900N

T. Insel, B. Cuthbert, and . Medicine, Brain disorders? Precisely, Science, vol.348, issue.6234, pp.499-500, 2015.
DOI : 10.1126/science.aab2358

J. Kantrowitz and D. Javitt, Glutamatergic transmission in schizophrenia, Current Opinion in Psychiatry, vol.25, issue.2, pp.96-102, 2012.
DOI : 10.1097/YCO.0b013e32835035b2

J. Dalmau, A. Gleichman, E. Hughes, J. Rossi, X. Peng et al., Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, The Lancet Neurology, vol.7, issue.12, pp.1091-1099, 2008.
DOI : 10.1016/S1474-4422(08)70224-2

E. Hughes, X. Peng, A. Gleichman, M. Lai, L. Zhou et al., Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis, Journal of Neuroscience, vol.30, issue.17, pp.5866-75, 2010.
DOI : 10.1523/JNEUROSCI.0167-10.2010

L. Mikasova, D. Rossi, P. Bouchet, D. Georges, F. Rogemond et al., Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis, Brain, vol.135, issue.5, pp.1606-1627, 2012.
DOI : 10.1093/brain/aws092
URL : https://hal.archives-ouvertes.fr/hal-01160045

J. Planaguma, F. Leypoldt, F. Mannara, J. Gutierrez-cuesta, E. Martin-garcia et al., Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice, Brain, vol.138, issue.1, pp.94-109, 2015.
DOI : 10.1093/brain/awu310

E. Coutinho, P. Harrison, and A. Vincent, Do Neuronal Autoantibodies Cause Psychosis? A Neuroimmunological Perspective, Biological Psychiatry, vol.75, issue.4, pp.269-75, 2014.
DOI : 10.1016/j.biopsych.2013.07.040

J. Dalmau, E. Lancaster, E. Martinez-hernandez, M. Rosenfeld, and R. Balice-gordon, Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, The Lancet Neurology, vol.10, issue.1, pp.63-74, 2010.
DOI : 10.1016/S1474-4422(10)70253-2

R. Schwarcz, J. Bruno, P. Muchowski, and H. Wu, Kynurenines in the mammalian brain: when physiology meets pathology, Nature Reviews Neuroscience, vol.19, issue.7, pp.465-77, 2012.
DOI : 10.1038/nrn3257

J. Marquard, S. Otter, A. Welters, A. Stirban, A. Fischer et al., Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment, Nature Medicine, vol.54, issue.4, pp.363-72, 2015.
DOI : 10.1038/nm.3822

C. Sharp, M. Fowler, T. Jackson, J. Houghton, A. Warren et al., Human neuroepithelial cells express NMDA receptors, BMC Neuroscience, vol.4, issue.1, p.28, 2003.
DOI : 10.1186/1471-2202-4-28

A. Reijerkerk, G. Kooij, S. Van-der-pol, T. Leyen, K. Lakeman et al., The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier, Journal of Neurochemistry, vol.57, issue.2, pp.447-53, 2010.
DOI : 10.1111/j.1471-4159.2010.06598.x

Y. Ganor, M. Besser, N. Ben-zakay, T. Unger, and M. Levite, Human T Cells Express a Functional Ionotropic Glutamate Receptor GluR3, and Glutamate by Itself Triggers Integrin-Mediated Adhesion to Laminin and Fibronectin and Chemotactic Migration, The Journal of Immunology, vol.170, issue.8, pp.4362-72, 2003.
DOI : 10.4049/jimmunol.170.8.4362

M. Bozic and J. Valdivielso, The potential of targeting NMDA receptors outside the CNS, Expert Opinion on Therapeutic Targets, vol.64, issue.10, pp.399-413, 2015.
DOI : 10.1016/0304-3940(94)90740-4

J. Scannell, A. Blanckley, H. Boldon, and B. Warrington, Diagnosing the decline in pharmaceutical R&D efficiency, Nature Reviews Drug Discovery, vol.393, issue.3, pp.191-200, 2012.
DOI : 10.1038/nrd3681

D. Baumeister, S. Ciufolini, and V. Mondelli, Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?, Psychopharmacology, vol.37, issue.Suppl 1, pp.1575-89, 2016.
DOI : 10.1007/s00213-015-4044-5

E. Torrey, J. Bartko, Z. Lun, and R. Yolken, Antibodies to Toxoplasma gondii in Patients With Schizophrenia: A Meta-Analysis, Schizophrenia Bulletin, vol.33, issue.3, pp.729-765, 2007.
DOI : 10.1093/schbul/sbl050

A. Sutterland, G. Fond, A. Kuin, M. Koeter, R. Lutter et al., in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis, Acta Psychiatrica Scandinavica, vol.38, issue.Pt 5, pp.161-79, 2015.
DOI : 10.1111/acps.12423

G. Fond, L. Boyer, A. Gaman, H. Laouamri, D. Attiba et al., Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: A cross-sectional study, Journal of Psychiatric Research, vol.63, pp.58-64, 2015.
DOI : 10.1016/j.jpsychires.2015.02.011

O. Dean, M. Maes, M. Ashton, L. Berk, B. Kanchanatawan et al., Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial, Clinical Psychopharmacology and Neuroscience, vol.12, issue.3, pp.180-188, 2014.
DOI : 10.9758/cpn.2014.12.3.180

I. Sommer, L. De-witte, M. Begemann, and R. Kahn, Nonsteroidal Anti-Inflammatory Drugs in Schizophrenia, The Journal of Clinical Psychiatry, vol.73, issue.04, pp.414-423, 2012.
DOI : 10.4088/JCP.10r06823

W. Laan, D. Grobbee, J. Selten, C. Heijnen, R. Kahn et al., Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders, The Journal of Clinical Psychiatry, vol.71, issue.05, pp.520-527, 2010.
DOI : 10.4088/JCP.09m05117yel

K. Na, K. Lee, J. Lee, Y. Cho, and H. Jung, Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.48, pp.79-85, 2014.
DOI : 10.1016/j.pnpbp.2013.09.006

R. Iyengar, S. Gandhi, A. Aneja, K. Thorpe, L. Razzouk et al., NSAIDs Are Associated with Lower Depression Scores in Patients with Osteoarthritis, The American Journal of Medicine, vol.126, issue.11, pp.1017-1028, 2013.
DOI : 10.1016/j.amjmed.2013.02.037

M. Berk, O. Dean, S. Cotton, S. Jeavons, M. Tanious et al., -Acetylcysteine in Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.75, issue.06, pp.628-664, 2014.
DOI : 10.4088/JCP.13m08454
URL : https://hal.archives-ouvertes.fr/hal-01023347

P. Zanos, R. Moaddel, P. Morris, P. Georgiou, J. Fischell et al., NMDAR inhibition-independent antidepressant actions of ketamine metabolites, Nature, vol.192, issue.7604, pp.481-487, 2016.
DOI : 10.1038/nature17998

E. Chang, M. Zarate, M. Rabaglino, E. Richards, T. Arndt et al., Ketamine decreases inflammatory and immune pathways after transient hypoxia in late gestation fetal cerebral cortex, Physiological Reports, vol.4, issue.6, p.12741, 2016.
DOI : 10.14814/phy2.12741

A. Cattaneo, M. Gennarelli, R. Uher, G. Breen, A. Farmer et al., Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ???Predictors??? and Longitudinal ???Targets???, Neuropsychopharmacology, vol.28, issue.3, pp.377-85, 2013.
DOI : 10.1038/npp.2011.277

V. Mondelli, S. Ciufolini, B. Murri, M. Bonaccorso, S. et al., Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis, Schizophrenia Bulletin, vol.41, issue.5, pp.1162-70, 2015.
DOI : 10.1093/schbul/sbv028

R. Girgis, S. Kumar, and A. Brown, The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies, Biological Psychiatry, vol.75, issue.4, pp.292-301, 2014.
DOI : 10.1016/j.biopsych.2013.12.002

H. Perron, N. Hamdani, R. Faucard, M. Lajnef, S. Jamain et al., Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder, Translational Psychiatry, vol.38, issue.12, p.201, 2012.
DOI : 10.1038/nm0510-517
URL : https://hal.archives-ouvertes.fr/inserm-00807038

F. Curtin, A. Lang, H. Perron, M. Laumonier, V. Vidal et al., GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis???Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study, Clinical Therapeutics, vol.34, issue.12, pp.2268-78, 2012.
DOI : 10.1016/j.clinthera.2012.11.006

B. Elmer and A. Mcallister, Major histocompatibility complex class I proteins in brain development and plasticity, Trends in Neurosciences, vol.35, issue.11, pp.660-70, 2012.
DOI : 10.1016/j.tins.2012.08.001

B. Abazyan, J. Nomura, G. Kannan, K. Ishizuka, K. Tamashiro et al., Prenatal Interaction of Mutant DISC1 and Immune Activation Produces Adult Psychopathology, Biological Psychiatry, vol.68, issue.12, pp.1172-81, 2010.
DOI : 10.1016/j.biopsych.2010.09.022